Addiction treatment in New York

Three things shape whether a person in New York can access treatment: where they live in the state, what insurance they carry, and which clinician answers the first call. The 796 licensed facilities do not change that calculus; they constrain the choices within it.

The Medicaid question

New York expanded Medicaid in 2014 under the Affordable Care Act. This single policy decision shapes access more than any other single factor. Has realistic access to Medicaid coverage for addiction treatment once enrolled. The states that expanded tend to see meaningfully higher treatment engagement; the states that did not tend to push low-income adults into the state-funded margin, where capacity runs out faster than demand.

The overdose-mortality context

The CDC puts New York's 2023 overdose mortality at 30.5 per 100,000. Whether that number is going up or down week-to-week matters less than where it concentrates, which is uneven: New York City fentanyl mortality versus upstate rural provider-network thinness

How access actually works in New York

The 796 facilities in New York are not interchangeable. Ownership structure, clinical framework, payer mix, and MAT availability vary enough that "any rehab" and "a good rehab for this person" are materially different propositions. New York City fentanyl mortality versus upstate rural provider-network thinness — so the search is less about proximity than about fit.

What to do next

In New York, the most underused resource is the PCP. Primary care has expanded its role in addiction treatment substantially since 2020 — buprenorphine prescribing, naltrexone administration, referrals into the evidence-based portion of the network — and a 30-minute PCP appointment often produces more useful direction than a 30-minute call with a treatment-center admissions counselor whose incentives are commercial.